StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc (WST) stock

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3032% above fair value
$416.42+5.12 (+1.24%)

Close on Nov 13, 2026Market cap $29.01BP/E 46.7Yield 0.21%

West Pharmaceutical Services r&d expenses

Research and development expenses are spending on new products and technology.

West Pharmaceutical Services's R&D Expenses for the twelve months ending Sep 30, 2026 was $75.60M, up 6.5% year over year. For fiscal 2025 it was $74.30M, up 7.5% from the year before. Over ten years it grew 8.1% a year on average. The highest annual figure on record is $74.30M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$74.30M+7.5%
FY2024Dec 31, 2024$69.10M+1.0%
FY2023Dec 31, 2023$68.40M+16.9%
FY2022Dec 31, 2022$58.50M+10.8%
FY2021Dec 31, 2021$52.80M+12.6%
FY2020Dec 31, 2020$46.90M+20.6%
FY2019Dec 31, 2019$38.90M-3.5%
FY2018Dec 31, 2018$40.30M+3.1%
FY2017Dec 31, 2017$39.10M+6.3%
FY2016Dec 31, 2016$36.80M+7.9%
FY2015Dec 31, 2015$34.10M-8.6%
FY2014Dec 31, 2014$37.30M-1.6%
FY2013Dec 31, 2013$37.90M+14.2%
FY2012Dec 31, 2012$33.20M+14.1%
FY2011Dec 31, 2011$29.10M+21.8%
FY2010Dec 31, 2010$23.90M+20.1%
FY2009Dec 31, 2009$19.90M+6.4%
FY2008Dec 31, 2008$18.70M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$18.30M+7.0%
Q2 FY2026Jun 30, 2026$19.70M+3.1%
Q1 FY2026Mar 31, 2026$15.80M-3.1%
Q4 FY2025Dec 31, 2025$21.80M+17.8%
Q3 FY2025Sep 30, 2025$17.10M+10.3%
Q2 FY2025Jun 30, 2025$19.10M+9.1%
Q1 FY2025Mar 31, 2025$16.30M-7.4%
Q4 FY2024Dec 31, 2024$18.50M+0.5%
Q3 FY2024Sep 30, 2024$15.50M-5.5%
Q2 FY2024Jun 30, 2024$17.50M+6.1%
Q1 FY2024Mar 31, 2024$17.60M+2.9%
Q4 FY2023Dec 31, 2023$18.40M+15.7%
Q3 FY2023Sep 30, 2023$16.40M+20.6%
Q2 FY2023Jun 30, 2023$16.50M+14.6%
Q1 FY2023Mar 31, 2023$17.10M+17.1%
Q4 FY2022Dec 31, 2022$15.90M+16.1%
Q3 FY2022Sep 30, 2022$13.60M+3.8%
Q2 FY2022Jun 30, 2022$14.40M+4.3%
Q1 FY2022Mar 31, 2022$14.60M+19.7%
Q4 FY2021Dec 31, 2021$13.70M+6.2%
Q3 FY2021Sep 30, 2021$13.10M+4.8%
Q2 FY2021Jun 30, 2021$13.80M+27.8%
Q1 FY2021Mar 31, 2021$12.20M+14.0%
Q4 FY2020Dec 31, 2020$12.90M+26.5%
Q3 FY2020Sep 30, 2020$12.50M+34.4%
Q2 FY2020Jun 30, 2020$10.80M+12.5%
Q1 FY2020Mar 31, 2020$10.70M+9.2%
Q4 FY2019Dec 31, 2019$10.20M+4.1%
Q3 FY2019Sep 30, 2019$9.30M-7.9%
Q2 FY2019Jun 30, 2019$9.60M-11.1%
Q1 FY2019Mar 31, 2019$9.80M+2.1%
Q4 FY2018Dec 31, 2018$9.80M+1.0%
Q3 FY2018Sep 30, 2018$10.10M+11.0%
Q2 FY2018Jun 30, 2018$10.80M+8.0%
Q1 FY2018Mar 31, 2018$9.60M-6.8%
Q4 FY2017Dec 31, 2017$9.70M+1.0%
Q3 FY2017Sep 30, 2017$9.10M–
Q2 FY2017Jun 30, 2017$10.00M–
Q1 FY2017Mar 31, 2017$10.30M–
Q4 FY2016Dec 31, 2016$9.60M–

More West Pharmaceutical Services figures

See a number that looks wrong?